Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 175 of 401 entries
View as:

Study on the Efficacy of Autologous Fat Grafting in Improving Hair Transplantation Outcomes for Patients With Localized Scleroderma-Related Alopecia

Phase: N/A Priority: Normal
NCT ID: NCT06646146 Org: User:
Start: 10/31/24 End: 05/01/26 Due: 05/01/27

Platelet Transfusion in HBV-related acute-on Chronic Liver Failure

Phase: N/A Priority: Normal
NCT ID: NCT03713489 Org: User:
Start: 10/01/18 End: 09/30/19 Due: 09/30/20

Virtual Hepatic Venous Pressure Gradient (vHVPG) With CT Angiography (CHESS1601)

Phase: N/A Priority: Normal
NCT ID: NCT02842697 Org: User:
Start: 08/31/16 End: 04/30/17 Due: 04/30/18

Optical Biopsy for Distal Margin in Low Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04016948 Org: User:
Start: 06/28/17 End: 05/01/21 Due: 05/01/22

Clinical Significance of DKK2 Protein in Cerebral Ischemia-reperfusion Injury

Phase: N/A Priority: Normal
NCT ID: NCT05585255 Org: User:
Start: 09/01/22 End: 09/30/24 Due: 09/30/25

Treat-to-target Strategy in Ankylosing Spondylitis Using Etanercept and Conventional Synthetic DMARDs

Phase: N/A Priority: Normal
NCT ID: NCT04077957 Org: User:
Start: 10/07/19 End: 07/02/22 Due: 07/02/23

Neoadjuvant Therapy of Anlotinib Combined With Toripalimab and Chemotherapy for Resectable Esophageal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT05996484 Org: User:
Start: 09/30/23 End: 07/31/26 Due: 07/31/27

ATG in HLA-matched Sibling HSCT as GVHD Prophylaxis

Phase: N/A Priority: Normal
NCT ID: NCT04203108 Org: User:
Start: 09/01/19 End: 12/31/22 Due: 12/31/23

TKI Therapy Based on Molecular Monitoring in Allogeneic-HSCT Recipients With Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01883219 Org: User:
Start: 06/30/13 End: 11/30/17 Due: 11/30/18

A Bidirectional Study in Exploring the Dynamic Changes of Plasma and Urine Metabolites of Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05969262 Org: User:
Start: 03/25/23 End: 06/01/25 Due: 06/01/26

A Multicenter Study Based on Multi-omics Analysis to Predict the Early Prognosis and Recurrence Risk of Acute Ischemic Stroke

Phase: N/A Priority: Normal
NCT ID: NCT06584565 Org: User:
Start: 01/30/24 End: 12/31/28 Due: 12/31/29

Integrative Multi-Omics Testing for Immunotherapy Response in Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05928299 Org: User:
Start: 01/01/20 End: 12/31/25 Due: 12/31/26

Combination of Sorafenib With Standard Therapy in Newly Diagnosed Adult CBF AML

Phase: N/A Priority: Normal
NCT ID: NCT05404516 Org: User:
Start: 01/01/20 End: 12/31/23 Due: 12/31/24

3E Extension Study

Phase: N/A Priority: Normal
NCT ID: NCT01834508 Org: User:
Start: 03/31/13 End: 12/31/16 Due: 12/31/17

Dielectric Property Test Compared With Frozen Pathological Section in the Rapid Diagnosis of Lung Nodules/Mass

Phase: N/A Priority: Normal
NCT ID: NCT03339479 Org: User:
Start: 05/25/17 End: 05/24/20 Due: 05/24/21

Clinical Efficacy of Ceramic vs Resin Block Endocrown

Phase: N/A Priority: Normal
NCT ID: NCT04033380 Org: User:
Start: 05/02/19 End: 10/31/21 Due: 10/31/22

Endocrown and 90° Shoulder Endocrown

Phase: N/A Priority: Normal
NCT ID: NCT03398395 Org: User:
Start: 03/01/17 End: 06/30/23 Due: 06/30/24

Efficacy Optimizing Extension Study of Chronic Hepatitis B Patients With Inadequate Response to NUC Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01829685 Org: User:
Start: 03/31/13 End: - Due: -

Zebutinib Combined With Immunochemotherapy in the Treat of Newly Treated CLL Patients Without 17p-/TP53 Mutation

Phase: N/A Priority: Normal
NCT ID: NCT04980859 Org: User:
Start: 09/01/21 End: 09/01/25 Due: 09/01/26

Sorafenib for Prophylaxis of Leukemia Relapse in Allo-HSCT Recipients With FLT3-ITD Positive AML

Phase: N/A Priority: Normal
NCT ID: NCT02474290 Org: User:
Start: 06/20/15 End: 08/10/19 Due: 08/10/20

Non-invasive Method for Predicting the Presence of Gastroesophageal Varices in Patients With Cirrhosis-a Prospective, Multicenter Trial

Phase: N/A Priority: Normal
NCT ID: NCT04890730 Org: User:
Start: 11/01/20 End: 10/30/24 Due: 10/30/25

Dapagliflozin Efficacy and Action in PCOS

Phase: N/A Priority: Normal
NCT ID: NCT04213677 Org: User:
Start: 03/20/20 End: 11/01/22 Due: 11/01/23

Comparison of Diagnostic Sensitivity Between ctDNA Methylation and CEA in Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05558436 Org: User:
Start: 06/01/22 End: 12/31/24 Due: 12/31/25

Long-term Prognosis and Quality of Life in Early Rheumatoid Arthritis Patients Treated by 2015 ACR Guideline (LELAND)

Phase: N/A Priority: Normal
NCT ID: NCT03508713 Org: User:
Start: 05/13/18 End: 07/01/22 Due: 07/01/23

MR-based Models for Clinically Significant Portal Hypertension in Cirrhosis (CHESS1802)

Phase: N/A Priority: Normal
NCT ID: NCT03766880 Org: User:
Start: 12/04/18 End: 04/30/19 Due: 04/30/20